论文部分内容阅读
目的:探讨血必净用于胰腺炎病症的治疗效果;方法:选取2013年1月至2015年1月在我院进行胰腺炎治疗的58例患者作为研究对象,将其随机分成观察组29例(血必净治疗)和对照组29例(常规治疗),对比两组患者的治疗效果;结果:观察组患者的治疗有效率为96.56%,腹痛腹胀缓解时间为5.3±2.1天,对照组的治疗有效率为86.21%,腹痛腹胀缓解时间为6.8±3.2天,两组患者在治疗效果及腹痛腹胀缓解时间方面相比差异具有显著性(P<0.05);结论:血必净注射液用于治疗急性胰腺炎,能够有效改善血液炎性变化,促进血液循环恢复正常,降低身体炎性反应,从而大大降低多器官复杂的并发症发生率,降低患者病死率。提高了患者的生活质量,患者预后较好,具有实际临床推广应用价值。
Objective: To investigate the effect of Xuebijing in the treatment of pancreatitis. Methods: Fifty-eight patients with pancreatitis treated in our hospital from January 2013 to January 2015 were selected and randomly divided into observation group (n = 29) (Xuebijing treatment) and control group (routine treatment), and 29 patients in the control group were treated with conventional therapy. Results: The effective rate of treatment was 96.56% in the observation group and 5.3 ± 2.1 days in the abdominal pain control group The effective rate of treatment was 86.21%, and the duration of abdominal pain and abdominal distension was 6.8 ± 3.2 days. There was significant difference between the two groups in the therapeutic effect and the time of relieving abdominal pain and bloating (P <0.05). Conclusion: Xuebijing Injection The treatment of acute pancreatitis can effectively improve the blood inflammatory changes, promote normal blood circulation and reduce the body inflammatory response, thereby greatly reducing the incidence of complications of multiple organs and reducing patient mortality. Improve the quality of life of patients, patients with better prognosis, with practical clinical application value.